Dr. Bruce Stein, MD
What this data tells you about Dr. Stein
Dr. Bruce Stein is a cardiovascular disease in Orlando, FL, with 20 years in practice. Based on federal Medicare data, Dr. Stein performed 18,809 Medicare services across 5,689 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stein received a total of $220,120 from 18 pharmaceutical and/or device companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 10,012 | $0 | $4 |
| Office visit, established patient (30-39 min) | 1,687 | $85 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,139 | $44 | $100 |
| Electrocardiogram (EKG), 12-lead | 646 | $10 | $80 |
| Office visit, established patient (20-29 min) | 487 | $61 | $110 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 467 | $311 | $2,600 |
| Echocardiogram, transthoracic | 387 | $137 | $1,276 |
| Electrocardiogram (ecg) 1 to 3 leads | 385 | $4 | $15 |
| Anticoagulant management of patient taking warfarin | 381 | $8 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 352 | $48 | $332 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 240 | $347 | $458 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 234 | $1,143 | $5,000 |
| Remote pacemaker/defibrillator monitoring, 90 days | 218 | $15 | $90 |
| Remote pacemaker monitoring, 90 days | 196 | $21 | $90 |
| Remote patient monitoring management, 20 min/month | 184 | $36 | $150 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 162 | $26 | $125 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 141 | $18 | $85 |
| Remote patient monitoring device, 30 days | 123 | $36 | $180 |
| Hospital follow-up visit, moderate complexity | 122 | $63 | $100 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 121 | $321 | $1,953 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 107 | $31 | $120 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 99 | $38 | $150 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 93 | $137 | $540 |
| New patient office visit (45-59 min) | 93 | $117 | $215 |
| Heart rhythm recording of continous external ekg over 8-15 days | 75 | $9 | $60 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 75 | $20 | $125 |
| Programming of dual lead pacemaker system | 65 | $55 | $201 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 56 | $9 | $45 |
| Cardiac catheterization | 56 | $780 | $5,861 |
| Initial hospital admission, moderate complexity | 56 | $96 | $175 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 55 | $18 | $75 |
| Injection of chemical agent into multiple incompetent veins of leg | 49 | $143 | $600 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 42 | $9 | $30 |
| Hospital follow-up visit, high complexity | 42 | $94 | $130 |
| Coronary stent placement | 29 | $451 | $3,267 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 23 | $860 | $6,311 |
| Ultrasound of leg arteries or artery grafts | 22 | $174 | $520 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 21 | $29 | $180 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 20 | $20 | $75 |
| External shock to heart to regulate heart beat | 17 | $112 | $375 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 17 | $86 | $375 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $937 | $6,861 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (100%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Stein is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Stein experienced with contrast dye for imaging (iodine-based)?
Does Dr. Stein receive payments from pharmaceutical companies?
How do Dr. Stein's costs compare to other cardiovascular diseases in Orlando?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology